Generic dossier
Alprostadil
0.5 mg/mL · Injection · Vasodilator
Product data
- Strength
- 0.5 mg/mL
- Dosage form
- Injection
- Dosage-form group
- Injectable
- Therapeutic area
- Vasodilator
- Market
- EU/US
- Status
- Dossier target · Dec 2026
- Development status
- Validation batch completed
- Portfolio
- Generic dossier
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23